allylamine has been researched along with Hyperlipemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Esan, O; Viljoen, A; Wierzbicki, AS | 1 |
| Liu, J; Qian, C; St Peter, WL; Ye, X | 1 |
| Jones, MR; Nwose, OM | 1 |
| Ford, DM; Gavin, JR; Jones, MR; Truitt, KE | 1 |
| Robinson, JG | 1 |
| Wright, WL | 1 |
| Bangit, JR; Batsell, RR; John, S; Molinella, R; Reddy, KJ; Singh, M; Varghese, S; Zaheer, MS | 1 |
| Freson, BJ; Garg, SK; Hazenfield, RM; Moser, EG; Ritchie, PJ; Snell-Bergeon, JK | 1 |
| Marrs, JC | 1 |
| Handelsman, Y; Hernandez-Triana, E; Jones, MR; Misir, S; Rosenstock, J | 1 |
| Goldberg, RB; Hernandez-Triana, E; Jones, MR; Misir, S; Rosenson, RS | 1 |
3 review(s) available for allylamine and Hyperlipemia
| Article | Year |
|---|---|
Role of colesevelam in combination lipid-lowering therapy.
Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipidemias | 2013 |
LDL reduction: how low should we go and is it safe?
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Muscular Diseases; Niacin; Risk Factors; Stroke | 2008 |
Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
Topics: Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypoglycemic Agents; Medication Adherence | 2012 |
3 trial(s) available for allylamine and Hyperlipemia
| Article | Year |
|---|---|
Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trial.
Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperlipidemias; Male; Middle Aged; Patient Compliance; Pilot Projects; Young Adult | 2011 |
Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes.
Topics: Allylamine; Anticholesteremic Agents; Apolipoproteins B; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Female; Glycated Hemoglobin; Hispanic or Latino; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Prediabetic State; Treatment Outcome | 2012 |
Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia.
Topics: Adult; Allylamine; Cholesterol, LDL; Colesevelam Hydrochloride; Constipation; Diarrhea; Double-Blind Method; Dyspepsia; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Intention to Treat Analysis; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Nuclear Magnetic Resonance, Biomolecular; Particle Size; Prediabetic State; Triglycerides | 2013 |
5 other study(ies) available for allylamine and Hyperlipemia
| Article | Year |
|---|---|
Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia.
Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperglycemia; Hyperlipidemias; Hypolipidemic Agents; Triglycerides | 2022 |
Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
Topics: Age Factors; Aged; Allylamine; Anticholesteremic Agents; Cohort Studies; Colesevelam Hydrochloride; Databases, Factual; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Hospitalization; Humans; Hyperlipidemias; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk Factors; Sex Factors; Stroke; Treatment Outcome | 2013 |
Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
Topics: Age Factors; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Randomized Controlled Trials as Topic | 2014 |
The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.
Topics: Allylamine; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Disease Progression; Drug Monitoring; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Life Style; Practice Guidelines as Topic; Risk Reduction Behavior; Treatment Outcome; United States | 2009 |
Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use.
Topics: Allylamine; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Monitoring; Drug Therapy, Combination; Ezetimibe; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Pulse Therapy, Drug; Pyrimidines; Pyrroles; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides | 2009 |